NBNRX
Price
$12.86
Change
+$0.04 (+0.31%)
Updated
Dec 26 closing price
VTMNX
Price
$15.47
Change
+$0.03 (+0.19%)
Updated
Dec 26 closing price
Ad is loading...

NBNRX vs VTMNX

Header iconNBNRX vs VTMNX Comparison
Open Charts NBNRX vs VTMNXBanner chart's image
Neuberger Berman International Sel R3
Price$12.86
Change+$0.04 (+0.31%)
VolumeN/A
CapitalizationN/A
Vanguard Developed Markets Index Instl
Price$15.47
Change+$0.03 (+0.19%)
VolumeN/A
CapitalizationN/A
NBNRX vs VTMNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NBNRX vs. VTMNX commentary
Dec 27, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NBNRX is a Buy and VTMNX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VTMNX has more cash in the bank: 198B vs. NBNRX (186M). VTMNX pays higher dividends than NBNRX: VTMNX (3.27) vs NBNRX (1.16). NBNRX was incepted earlier than VTMNX: NBNRX (16 years) vs VTMNX (24 years). NBNRX is a more actively managed with annual turnover of: 43.00 vs. VTMNX (3.00). NBNRX has a lower initial minimum investment than VTMNX: NBNRX (0) vs VTMNX (5000000). NBNRX annual gain was more profitable for investors over the last year : 2.25 vs. VTMNX (0.78). VTMNX return over 5 years is better than : 11.66 vs. NBNRX (0.04).
NBNRXVTMNXNBNRX / VTMNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years24 years-
Gain YTD2.4920.841296%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets186M198B0%
Annual Yield % from dividends1.163.2736%
Returns for 1 year2.250.78290%
Returns for 3 years-13.70-4.48305%
Returns for 5 years0.0411.660%
Returns for 10 years25.6232.3479%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LSAK5.350.19
+3.68%
Lesaka Technologies
IX106.570.56
+0.53%
ORIX Corp
PEBO32.470.01
+0.05%
Peoples Bancorp
CC17.33-0.21
-1.20%
Chemours Company (The)
OCX2.13-0.03
-1.39%
Oncocyte Corp